Anchyra Partners’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Buy
+12,160
New +$215K 0.05% 353
2026
Q2
– Sell
-12,466
Closed -$231K – 372
2026
Q1
$231K Buy
+12,466
New +$219K 0.07% 246

Other funds holding TAK

Anchyra Partners's TAK Position: Q3 2026 in Review

Anchyra Partners opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 12,160 shares worth $221K. The stake represents 0.05% of the portfolio and ranks #353 among its holdings. This is a return to the name: Anchyra Partners previously reported a position in TAK as recently as Q1 2026.

Anchyra Partners first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $231K in Q1 2026. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Anchyra Partners held 12,160 shares of Takeda Pharmaceutical worth $221K as of Q3 2026.
  • Takeda Pharmaceutical was a new Anchyra Partners position in Q3 2026.
  • Takeda Pharmaceutical made up 0.05% of Anchyra Partners's portfolio in Q3 2026, its #353 holding.
  • Anchyra Partners first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Anchyra Partners's Takeda Pharmaceutical position peaked at $231K in Q1 2026.
  • 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.